ABL1 and bronchopneumonia: The absence of extrapulmonary dissemination was detected in 33.3% (12/36) of patients (second group), and the median SARS-CoV-2 VL was 239 (range 18–1952) copies of SARS-CoV-2 cDNA per 100 copies of ABL1. At the same time, the histomorphological changes in the lungs corresponded to bronchopneumonia and the proliferative phase of DAD.